000			01990 a2200517 4500
005			20250513235922.0
264		0	_c20010531
008			200105s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2001.19.9.2370 _2doi
040			_aNLM _beng _cNLM
100	1		_aKirkwood, J M
245	0	0	_aHigh-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMay 2001
300			_a2370-80 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCancer Vaccines _ximmunology
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aG(M2) Ganglioside _ximmunology
650	0	4	_aHemocyanins _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aImmunoglobulin M _xblood
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadverse effects
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins
650	0	4	_aSaponins
650	0	4	_aVaccination
650	0	4	_aVaccines, Conjugate _ximmunology
700	1		_aIbrahim, J G
700	1		_aSosman, J A
700	1		_aSondak, V K
700	1		_aAgarwala, S S
700	1		_aErnstoff, M S
700	1		_aRao, U
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 19 _gno. 9 _gp. 2370-80
856	4	0	_uhttps://doi.org/10.1200/JCO.2001.19.9.2370 _zAvailable from publisher's website
999			_c11265110 _d11265110